Israel’s PolyPid is preparing to launch on NASDAQ. PolyPid, develops an antibiotic coating for safer bone repair. It also has two candidate bone grafting materials and a unique PLEX (Polymer-Lipid Encapsulation MatriX) mechanism for delivering medicine into the body.
http://jewishbusinessnews.com/2015/01/18/israels-polypid-revives-80-million-nasdaq-ipo-plan/